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TB bug inhibits any 
which way
 
ach new study of 
 
Mycobacterium tu-
berculosis
 
 (
 
Mtb
 
), the causative agent
of tuberculosis (TB), seems to come up
with a new resistance mechanism, and fails to
see evidence for the mechanisms claimed by
others. Now Stewart Chang, Jennifer Linderman,
and Denise Kirschner (University of Michigan,
Ann Arbor, MI) use a mathematical model to
conclude that multiple mechanisms operate.
Different mechanisms are best suited to pro-
tection under different conditions, and some
are masked by experimental protocols used
in previous studies.
 
Mtb
 
 prevents macrophages from doing
their job primarily by inhibiting antigen presen-
tation by MHC class II. The Michigan group
included four parts of this process (identified by
others) that could be inhibited: MHC transcrip-
tion; MHC protein maturation; antigen process-
ing; and peptide loading onto MHC. IFN-
 
 
 
 and
antigen got things going, and surface expres-
sion of peptide-loaded MHC was the readout.
Two inhibition classes served distinct time
frames: effects were immediate for inhibition
of antigen processing or peptide loading but
delayed for inhibition of MHC transcription or
maturation. The long pulses of IFN-
 
 
 
 used by
two previous groups resulted in inhibition medi-
ated primarily by effects on either maturation
or transcription, respectively, with some part
of the effect unexplained.
To suggest candidates for these unex-
plained effects, Kirschner and colleagues identi-
fied a number of processes whose inhibition in
silico has major effects on antigen presentation
efficiency. In vitro time series will allow many of
the model’s predictions to be tested. 
 
Reference: Chang, S.T., et al. 2005. 
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There are multiple TB resistance pathways in the cell.
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Split motifs
 
any more motifs may be lurking in proteins than previously ex-
pected. Randen Patterson (Pennsylvania State University, State Col-
lege, PA), Damian van Rossum, Solomon Snyder (Johns Hopkins
University, Baltimore, MD), and colleagues report that functional protein–lipid
interaction motifs can be formed when partial motifs from two proteins unite.
The group’s initial example of a split domain comes in the context of
a Ca
 
2
 
 
 
 entry system. In this system, neurotransmitters bind receptors that
trigger production of inositol 1,4,5-trisphosphate (IP3), which in turn
prompts release of intracellular Ca
 
2
 
 
 
 stores and entry of extracellular Ca
 
2
 
 
 
through TRPC3 channels. Snyder and colleagues previously established
that phospholipase C
 
 
 
1 (PLC-
 
 
 
1) was needed for this latter TRPC3 action,
independent of PLC-
 
 
 
1’s enzymatic activity in generating IP3.
They now report that the binding of TRPC3 and PLC-
 
 
 
1 to each other
brings together two halves of a split PH domain, a motif associated with the
binding of lipids and other proteins. Mutation of the partial PH domains
changes the lipid-binding profile of the TRPC3–PLC-
 
 
 
1 complex, and
reduces the amount of TRPC3 at the plasma membrane 24 h after stimulation.
M
 
The phenomenon of split
domains may be widespread. A
modified search algorithm spotted
not only the half-domains in TRPC3
and PLC-
 
 
 
1 but also split domains
in additional proteins. “It has opened
up a whole new world,” says
Snyder. “It will amplify perhaps
many-fold the number of protein
recognition motifs.” This profusion
of motifs, he says, allows the cell to
deliver on a promise: “Everything is
hand delivered.” 
 
Reference: van Rossum, D.B., et al.
2005. 
 
Nature.
 
 434:99–104.
Only TRPC3 (WT) combined with PLC- 1 
generates a PH domain that binds lipids.
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PML goes to the centrosome
 
he promyelocytic leukemia gene (PML) has “too many things it is
involved in,” says Kun-Sang Chang (University of Texas MD
Anderson Cancer Center, Houston, TX). But now Chang, Zhi-Xiang
Xu, and colleagues have added another function: the PML3 isoform prevents
centrosome reduplication.
PML has at least 7 isoforms but most studies have used only one
(PML4). Chang developed isoform-specific antibodies and saw that PML3
antibodies gave staining that coincided with that of centrosome proteins.
Knock-down by siRNA of PML3, but not of other PML isoforms, resulted in
centrosome amplification. And only PML3 interacted with and, when over-
expressed, reduced the phosphorylation of Aurora A kinase.
It is known that in cells with activated Aurora A kinase there is a failure
to inhibit Cdk2/cyclin E, leading to reduplication of centrosomes. Cells
lacking PML had higher levels of Cdk2 kinase activity, which could explain
the centrosome reduplication. What is signaling to PML from upstream
is still mysterious, but the new findings certainly provide one possible
explanation for why PML is lost in so many tumor types. 
 
Reference: Xu, Z.-X., et al. 2005. 
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